Your browser doesn't support javascript.
loading
Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance.
Cleaver, Amanda L; Bhamidipaty, Kasia; Wylie, Ben; Connor, Theresa; Robinson, Cleo; Robinson, Bruce W; Mutsaers, Steven E; Lake, Richard A.
Afiliação
  • Cleaver AL; National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia 6009, Australia and.
Carcinogenesis ; 35(2): 407-14, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24130165
Simian virus 40 (SV40) has been implicated in the development of several cancers including malignant mesothelioma. A definitive role for the virus in human mesothelioma has not been unequivocally demonstrated but has been rigorously debated. The virus clearly has oncogenic potential: the TAg is one of the most potent transforming proteins known and acts synergistically with crocidolite asbestos to transform mesothelial cells. In this study, we show that SV40 oncogenes alone can cause malignant transformation and that asbestos-induced DNA damage and apoptosis occurs principally in cycling cells. After long-term exposure (up to 100 days) to both SV40 and asbestos, cells become resistant to stress-induced senescence. Significantly, these cells demonstrate resistance to chemotherapy-induced apoptosis. This finding has implications for the development of effective treatment options for patients with mesothelioma.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Antígenos Transformantes de Poliomavirus / Cocarcinogênese / Asbesto Crocidolita / Resistencia a Medicamentos Antineoplásicos / Neoplasias Pulmonares / Mesotelioma Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Antígenos Transformantes de Poliomavirus / Cocarcinogênese / Asbesto Crocidolita / Resistencia a Medicamentos Antineoplásicos / Neoplasias Pulmonares / Mesotelioma Idioma: En Ano de publicação: 2014 Tipo de documento: Article